Skip to main content

Advertisement

Table 1 Patient baseline characteristics and demographics

From: Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN)

   radiochemotherapy radioimmunotherapy TPF induction
site   pts, (%)   
  hypopharynx 17 (44.7) 3 (7.9) 5 (31.3)
  oropharynx 7 (18.4) 6 (15.8) 3 (18.8)
  base of tongur 5 (13.2) 4 (10.5) 1 (6.3)
  oral cavity 4 (10.5) 12 (31.6) 1 (6.3)
  oro-/hypopharynx 3 (7.9) 5 (13.2) 3 (18.8)
  larynx 1 (2.6) 7 (18.4) 1 (6.3)
  oropharynx+hypopharynx 1 (2.6)   1 (6.3)
  lip   1 (2.6)  
stage T1 1 (2.6) 6 (15.8)  
  T2 3 (7.9) 6 (15.8) 1 (6.3)
  T3 4 (10.5) 4 (10.5) 2 (12.5)
  T4 30 (78.9) 22 (57.9) 13 (81.3)
  N0 3 (7.9) 10 (26.3) 1 (6.3)
  N1 2 (5.3) 4 (10.5) 2 (12.5)
  N2a   3 (7.9)  
  N2b 5 (13.2) 6 (15.8) 4 (25)
  N2c 23 (60.5) 15 (39.5) 8 (50)
  N3 4 (10.5)   1 (6.3)
  pN2b 1 (2.6)   
  M1 2 (5.3) 4 (10.5) 0
  primary treatment 35 (92.1) 26 (68.4) 15 (93.8)
  local relapse 3 (7.9) 12 (31.6) 1 (6.3)
  seconday tumours 2 (5.3) 2 (5.3) 2 (12.5)
Total   38 38 16
age [a] median 61.1 71.4 60.3
  range 17 - 74 50 - 85 17 - 68
   p < 0.001   p < 0.001